Bayer HealthCare - Homepage

Search

Bayer HealthCare worldwide

Financial Report

Stockholders' Newsletter Second Quarter 2008

Trasylol

The latest information about Trasylol.

Clinical trials

Information about clinical studies is available at database of
- Bayer HealthCare
- as well as at clinicaltrials.gov,
- clinicalstudyresults.org
- and clinicaltrials.ifpma.org

Press portal

In focus

Image: Arthur J. Higgins, Chairman of the Board of Management of Bayer HealthCare AG

Research-based pharmaceutical industry in Europe to celebrate 30. anniversary at Annual Meetings EFPIA President Higgins highlighted pharmaceutical industry’s contribution to health and wealth of EU citizens. more

News

09/02/08, Cardiology/Hematology Bayer Submits Recombinant Human Thrombin for European Approval Recothrom® would be the first recombinant human thrombin for use as a topical aid to surgical hemostasis in Europe more

08/31/08, Thrombosis Rivaroxaban Phase II Data in ACS to be Presented at AHA Congress in November 2008 First data presentation from large dose-finding trial involving about 3,500 patients / Acceleration of clinical development in acute coronary syndrome planned more

Science for a better life

From world-renowned pharmaceutical products to high-tech platforms, from innovative diagnostics technologies to veterinary medicines – Bayer HealthCare is a globally researching healthcare company.

Berlin: Diagnostic Imaging, Oncology, Women’s Healthcare
Wuppertal: Hematology/Cardiology
Berkeley: Biologics

Search

Font size

Page tools